This user helped "Amphetamine" become a featured article on January 14, 2015.
This user helped "Amphetamine" become a good article on November 30, 2013.
This user helped "Methamphetamine" become a good article on January 27, 2014.
This user helped "Adderall" become a good article on December 3, 2014.
This user drew "File:TAAR1 Dopamine.svg", a valued image on Wikimedia Commons within the scope "Category:Amphetamine, pharmacodynamics." (March 19, 2014)‎
This user drew "File:TAAR1 Dopamine.svg", a quality image on Wikimedia Commons. (March 30, 2014)
This user has AutoWikiBrowser permissions on the English Wikipedia.

User:Seppi333

From Wikipedia, the free encyclopedia
Jump to: navigation, search


Reliability of Wikipedia
Semi-related to writing Wikipedia: [1][2]


I have an academic background in mathematics, statistics, finance, and economics. I have a general interest in and deep knowledge of molecular neuropharmacology as well, primarily in relation to neuropsych disorders and basically anything remotely related to monoamine neurotransmission (e.g., signal transduction in associated pathways, neural pathway interactions, and pharmacodynamics/pharmacogenomics of relevant drugs).
I generally only edit articles on topics related to neurology, psychology, pharmacology, molecular biology, medicine, statistics, or econometrics. I also spend a fair amount of time wikignoming and continuously donate my 2¢ to WT:MED since I'm generous like that.

Seppi333
Animal Cell Unannotated.svg This user is a member of the Molecular & Cell Bio. WikiProject.
Rod of asclepius.png This user is a member of WikiProject Medicine.
Penicillin core.svg This user is a member of WikiProject Pharmacology.
Brain logo.svg This user contributes to the Neuroscience WikiProject.
Plato-raphael.jpg This user has published peer-reviewed articles in academic journals.
FSM.svg This user is a devout worshipper of His Noodliness.
Wikipedia-logo-v2.svg This user is severely addicted to Wikipedia.
Book3.svg This user is an autodidact in subjects that he never studied at a university.
*.* This user has ADOS:
Attention Deficit OOH Shiny
Cscr-featured.svg This user is currently trying to promote the article β-Hydroxy β-methylbutyric acid to featured article status.
Red barnstar.png This user is a recipient of the
Editor of the Week award.
Tentative unprioritized future article editing plans
Pharmacology/Molecular biology Intent Neuroscience/Neuropsychology Intent Statistics/Econometrics Intent
β-Hydroxy β-methylbutyric acid‎‎ Featured article Neurobiological effects of physical exercise Featured article Structural break
TAAR1 Reward system Fundamental factor model create
Trace amine Incentive salience
FOSB/ΔFosB Rostromedial tegmental nucleus
My contributions to Wikipedia
  1. Amphetamine - (Page statistics) (Also: Adderall and dextroamphetamine mostly through transclusions)
  2. Methamphetamine - (Page statistics)
  3. beta-Hydroxy beta-methylbutyric acid - (Page statistics)
  4. Neurobiological effects of physical exercise - in progress (Page statistics)
  • Examples of images I've drawn and annotated with wikitext markup
  1. Annotated image: {{Psychostimulant addiction}} (image file: File:ΔFosB.svg)
  2. Annotated image: {{Catecholamine and trace amine biosynthesis}} (image file: File:Catecholamine and trace amine biosynthesis.png)
  3. Annotated image: {{Amphetamine pharmacodynamics}} (image file: File:TAAR1 Dopamine.svg)
  4. Annotated image: {{Amphetamine pharmacokinetics}} (image file: File:Amph Pathway.png)
  • The image annotation template that I coded for overlaying wikitext:
{{Annotated image 4}}

Lastly, the most ridiculous article that I've come come across so far:

The result of
The image above contains clickable links
...that I created.

Cross-wiki userpage links[edit]

Links to my userpages on other Wikimedia projects where I contribute content:

Maintained articles and templates[edit]

Pages that I actively monitor or frequently edit

edit


For myself[edit]

Statistics articles for self-reference[edit]

Statistics/Econometrics/Regression analysis-related topics

Four possible cases of stationarity and nonstationarity (with an I(1) unit root) for regressors and the error term (yt=α+βxtt). The time-series behavior of y is governed by the behavior of x and μ:

Table 4.2: Regression methods with nonstationary variables
Regressor Error Dependent variable Proper estimation method
X is I(0) μ is I(0) y will be I(0) Estimate with standard distributed-lag model.
X is I(0) μ is I(1) y will be I(1) Misspecified model. Cannot explain a nonstationary dependent variable with stationary regressors.
X is I(1) μ is I(1) y will be I(1) First-difference model to make all variables stationary, then use standard distributed-lag models
X is I(1) μ is I(0) y will be I(1) Variables x and y are cointegrated. Use error-correction model

Medicine-related article alerts[edit]

Medicine article alerts

Articles for deletion
(3 more...)
Proposed deletions
Categories for discussion
Templates for discussion
Redirects for discussion
Featured list candidates
Good article nominees
Featured article reviews
Good article reassessments
Requests for comments
Requested moves

Preformatted talk header templates[edit]

{{talk header}}
{{WPBS      |  1=
{{WPPHARM   |  class =  | importance =  }}
{{WPMED     |  class =  | importance =  }}
{{WPNEURO   |  class =  | importance =  }}
{{WPMCB     |  class =  | importance =  }}
{{Chemicals |  class =  | importance =  }}
}}
{{Reliable sources for medical articles}}

Molecular neuropharmacology textbook[edit]

Graduate level[1]

<ref name="NHM-#">{{cite book | vauthors = Malenka RC, Nestler EJ, Hyman SE | editor = Sydor A, Brown RY | title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience | year = 2009 | publisher = McGraw-Hill Medical | location = New York | isbn = 9780071481274 | pages = XX–YY | edition = 2nd | chapter = Chapter #:XYZ | quote= }}</ref>

Econometrics textbooks[edit]

Undergraduate and master's level[2]

<ref name="Wooldridge Econometrics – X">{{cite book | author=Wooldridge, Jeffrey | title=Introductory Econometrics: A Modern Approach | date=2012 | publisher=South-Western Cengage Learning | isbn=9781111531041 | pages=XX–YY | edition=5th | chapter=Chapter #: XYZ }}</ref>

Graduate level[3]

<ref name="Greene Econometrics – X">{{cite book | author=Greene, William | title=Econometric Analysis | date=2012 | publisher=Pearson Education | isbn=9780273753568 | pages=XX–YY | edition=7th | chapter=Chapter #: XYZ}}</ref>

References

  1. ^ Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter #:XYZ". In Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. XX–YY. ISBN 9780071481274. 
  2. ^ Wooldridge, Jeffrey (2012). "Chapter #: XYZ". Introductory Econometrics: A Modern Approach (5th ed.). South-Western Cengage Learning. pp. XX–YY. ISBN 9781111531041. 
  3. ^ Greene, William (2012). "Chapter #: XYZ". Econometric Analysis (7th ed.). Pearson Education. pp. XX–YY. ISBN 9780273753568. 
Wikipedia:WikiProject Medicine
Recent changes in WP:Medicine
Articles and their talkpages:

Not mainspace:

 Top   High   Mid   Low   NA   ???  Total
92 990 9,134 19,882 7,793 10 37,901
List overview · Lists updated: 2015-07-15 · This box: view · talk

Useful page and syntax references + other content[edit]

Project space links and syntax references[edit]

MOS and popular page links
Other project space links
Templates
  • Redirect templates:
    • For redirects that result from a merge, use: {{tpr|target article name|merge=yes}} (Template:Talk page of redirect shortcut)
    • Category parameters for {{Redr}} are listed in the navbox below:
Amusing pages

Miscellaneous links and article content[edit]

Editor tools
  1. Edit history statistics
  2. Article contributor ranking
Other stuff
reflist

References

  1. ^ De Luca LA, Menani JV, Johnson AK (2014). Neurobiology of Body Fluid Homeostasis: Transduction and Integration. Boca Raton: CRC Press/Taylor & Francis. ISBN 9781466506930. Retrieved 23 July 2016. 
  2. ^ Kennedy DO (January 2016). "B Vitamins and the Brain: Mechanisms, Dose and Efficacy-A Review". Nutrients. 8 (2). doi:10.3390/nu8020068. PMC 4772032Freely accessible. PMID 26828517. Furthermore, evidence from human research clearly shows both that a significant proportion of the populations of developed countries suffer from deficiencies or insufficiencies in one or more of this group of vitamins, and that, in the absence of an optimal diet, administration of the entire B-vitamin group, rather than a small sub-set, at doses greatly in excess of the current governmental recommendations, would be a rational approach for preserving brain health. ...
    RDAs are population statistics and they therefore represent rough estimates of the average requirement of individuals within a group/population, with an adjustment for the variations in the need for the nutrient among the individuals that make up the population. However, for most micronutrients some of the information that would be required to accurately calculate the daily requirement is either unknown or incomplete, and the recommendations are therefore made on the basis of a number of assumptions and considerations that could lead to large variations in the eventual RDA [81,82]. These figures have also changed little in the last four decades, despite emerging evidence of striking individual differences in the absorption and excretion of vitamins as a consequence of a wide range of factors, including specific genetic polymorphisms, gender, ethnicity, endocrine dysfunction, thyroid function, the habitual co-consumption of medicines, drugs, alcohol and other dietary factors, obesity, overall energy consumption, vigorous exercise, and age [9,21,45,83,84,85,86]. These gaps in our knowledge question the very existence of a “normal” population [87], and suggest that RDAs are, to some extent, arbitrary figures.
    Government figures also show that sizeable minorities of the populations of developed countries fail to consume even the minimum recommended quantity of any given micronutrient. As an example, Troesch et al. [88] presented data showing that a sizeable proportion of the populations of the US and several European countries consume less than the RDA for each of the five B vitamins that they assessed. They note that “a gap exists between vitamin intakes and requirements for a significant proportion of the population”. As a result, studies assessing the blood levels of vitamins show that small but significant proportions of the populations of developed countries have biochemical levels of each of the B vitamins that may well predispose them to deficiency related diseases. ... For instance, recent US government data [91] demonstrated that 10.5% of the entire US population were biochemically deficient in vitamin B6. A subsequent independent analysis that excluded the substantial minority taking supplements containing vitamin B6 demonstrated much higher deficiency rates of between 23% and 27% for adults, depending on age [16].
     
  3. ^ Bragg DA, Walling A (2015). "Metabolic Syndrome: Hyperlipidemia". FP Essent. 435: 17–23. PMID 26280341. When metabolic syndrome includes lipid abnormalities, management goals are weight loss and cardiovascular risk management through lifestyle modifications (eg, diet, exercise), and, when appropriate, lowering of lipid levels with pharmacotherapy. ... Lipid levels should be reevaluated 4 to 12 weeks after initiating therapy; lipid levels can be measured without fasting. A lack of improvement often indicates nonadherence. Bile acid sequestrants, fibric acids, and niacin can be used if other drugs are not tolerated. 
  4. ^ McCarty MF, DiNicolantonio JJ (2014). "The molecular biology and pathophysiology of vascular calcification". Postgrad Med. 126 (2): 54–64. doi:10.3810/pgm.2014.03.2740. PMID 24685968. Vascular calcification (VC), commonly encountered in renal failure, diabetes, and aging, is associated with a large increase in the risk for cardiovascular events and mortality. Calcification of the arterial media and of heart valves clearly plays a mediating role in this regard, whereas it is less clear how calcification of plaque influences atherogenesis and risk for plaque rupture. Vascular calcification is an active process in which vascular smooth muscle cells (VSMCs) adopt an osteoblastic phenotype and deposit hydroxyapatite crystals; apoptosis of VSMCs also promotes this deposition. Drivers of this phenotypic transition, which include elevated serum phosphate, advanced glycation end-products, bone morphogenetic proteins, inflammatory cytokines, and leptin, invariably induce oxidative stress in VSMCs ... Antioxidants that suppress reduced nicotinamide adenine dinucleotide phosphate oxidase activity may have the potential to block the osteoblastic transition of VSMCs. Minimizing the absorption of dietary phosphate may also be helpful in this regard, particularly in renal failure, and it can be achieved with plant-based dietary choices, avoidance of phosphate additives, and administration of pharmaceutical phosphate binders, supplemental magnesium, and niacin. 

Cognitive control deteriorates (poorer reasoning and problem solving, forgetting things, and impaired ability to exercise discipline and self-control)[1] as a result of:

  • excessive stress[1]
  • sadness/depression[1]
  • social isolation/loneliness[1]
  • poor health[1]
  • lack of physical exercise/fitness[1]

Impaired cognitive control can produce symptoms of ADHD in adults who did not have the disorder as a child.[1]

Cognitive control can be improved[1] through:

References

  1. ^ a b c d e f g h i j Diamond A (2013). "Executive functions". Annu Rev Psychol. 64: 135–168. doi:10.1146/annurev-psych-113011-143750. PMC 4084861Freely accessible. PMID 23020641. Core EFs are inhibition [response inhibition (self-control—resisting temptations and resisting acting impulsively) and interference control (selective attention and cognitive inhibition)], working memory, and cognitive flexibility (including creatively thinking “outside the box,” seeing anything from different perspectives, and quickly and flexibly adapting to changed circumstances). ... EFs and prefrontal cortex are the first to suffer, and suffer disproportionately, if something is not right in your life. They suffer first, and most, if you are stressed (Arnsten 1998, Liston et al. 2009, Oaten & Cheng 2005), sad (Hirt et al. 2008, von Hecker & Meiser 2005), lonely (Baumeister et al. 2002, Cacioppo & Patrick 2008, Campbell et al. 2006, Tun et al. 2012), sleep deprived (Barnes et al. 2012, Huang et al. 2007), or not physically fit (Best 2010, Chaddock et al. 2011, Hillman et al. 2008). Any of these can cause you to appear to have a disorder of EFs, such as ADHD, when you do not. You can see the deleterious effects of stress, sadness, loneliness, and lack of physical health or fitness at the physiological and neuroanatomical level in prefrontal cortex and at the behavioral level in worse EFs (poorer reasoning and problem solving, forgetting things, and impaired ability to exercise discipline and self-control). ...
    EFs can be improved (Diamond & Lee 2011, Klingberg 2010). ... At any age across the life cycle EFs can be improved, including in the elderly and in infants. There has been much work with excellent results on improving EFs in the elderly by improving physical fitness (Erickson & Kramer 2009, Voss et al. 2011) ... Inhibitory control (one of the core EFs) involves being able to control one’s attention, behavior, thoughts, and/or emotions to override a strong internal predisposition or external lure, and instead do what’s more appropriate or needed. Without inhibitory control we would be at the mercy of impulses, old habits of thought or action (conditioned responses), and/or stimuli in the environment that pull us this way or that. Thus, inhibitory control makes it possible for us to change and for us to choose how we react and how we behave rather than being unthinking creatures of habit. It doesn’t make it easy. Indeed, we usually are creatures of habit and our behavior is under the control of environmental stimuli far more than we usually realize, but having the ability to exercise inhibitory control creates the possibility of change and choice.
     
  2. ^ a b Ilieva IP, Hook CJ, Farah MJ (January 2015). "Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis". J. Cogn. Neurosci.: 1–21. doi:10.1162/jocn_a_00776. PMID 25591060. Specifically, in a set of experiments limited to high-quality designs, we found significant enhancement of several cognitive abilities. ... The results of this meta-analysis ... do confirm the reality of cognitive enhancing effects for normal healthy adults in general, while also indicating that these effects are modest in size. 
  3. ^ a b Spencer RC, Devilbiss DM, Berridge CW (June 2015). "The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex". Biol. Psychiatry. 77 (11): 940–950. doi:10.1016/j.biopsych.2014.09.013. PMID 25499957. Collectively, this evidence indicates that at low, clinically relevant doses, psychostimulants are devoid of the behavioral and neurochemical actions that define this class of drugs and instead act largely as cognitive enhancers (improving PFC-dependent function). This information has potentially important clinical implications as well as relevance for public health policy regarding the widespread clinical use of psychostimulants and for the development of novel pharmacologic treatments for attention-deficit/hyperactivity disorder and other conditions associated with PFC dysregulation. ... In particular, in both animals and humans, lower doses maximally improve performance in tests of working memory and response inhibition, whereas maximal suppression of overt behavior and facilitation of attentional processes occurs at higher doses. 
  4. ^ a b c Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 13: Higher Cognitive Function and Behavioral Control". In Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York, USA: McGraw-Hill Medical. pp. 318, 321. ISBN 9780071481274. Therapeutic (relatively low) doses of psychostimulants, such as methylphenidate and amphetamine, improve performance on working memory tasks both in normal subjects and those with ADHD. ... stimulants act not only on working memory function, but also on general levels of arousal and, within the nucleus accumbens, improve the saliency of tasks. Thus, stimulants improve performance on effortful but tedious tasks ... through indirect stimulation of dopamine and norepinephrine receptors. ...
    Beyond these general permissive effects, dopamine (acting via D1 receptors) and norepinephrine (acting at several receptors) can, at optimal levels, enhance working memory and aspects of attention. Drugs used for this purpose include, as stated above, methylphenidate, amphetamines, atomoxetine, and desipramine.
     


Citations to read through later

Navigation templates[edit]